SEC Comment Letter 0000000000-23-002930 to Vaxart, Inc. (VXRT) (CIK 0000072444) (VXRT)
Vaxart, Inc. (VXRT) (CIK 0000072444)
Date: March 23, 2023 · CIK: 0000072444 · Accession: 0000000000-23-002930
AI Filing Summary & Sentiment
File numbers found in text: 333-270671
Letter
United States securities and exchange commission logo March 23, 2023 Andrei Floroiu Chief Executive Officer Vaxart, Inc. 170 Harbor Way, Suite 300 South San Francisco, CA 94080 Re:Vaxart, Inc. Registration Statement on Form S-3 Filed March 17, 2023 File No. 333-270671 Dear Andrei Floroiu: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tyler Howes at 202-551-3370 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Faith Charles, Esq.
Show Raw Text
United States securities and exchange commission logo
March 23, 2023
Andrei Floroiu
Chief Executive Officer
Vaxart, Inc.
170 Harbor Way, Suite 300
South San Francisco, CA 94080
Re:Vaxart, Inc.
Registration Statement on Form S-3
Filed March 17, 2023
File No. 333-270671
Dear Andrei Floroiu:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Tyler Howes at 202-551-3370 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Faith Charles, Esq.